Biontech to present multiple program updates across modalities at esmo congress 2023

Mainz, germany, october 16, 2023 – biontech se (nasdaq: bntx, “biontech” or “the company”) will present data across its oncology pipeline, covering multiple solid tumor types and novel mechanisms of action, at the european society for molecular oncology (“esmo”) congress 2023 in madrid, spain from october 20-24, 2023. the updates will feature oral and poster presentations for five candidates of biontech's clinical pipeline across the company's drug classes, which comprise mrna-based immunotherapies, cell therapies, protein-based therapeutics, and small molecules.
BNTX Ratings Summary
BNTX Quant Ranking